KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) EBT Margin (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of EBT Margin data on record, last reported at 5.76% in Q4 2025.

  • For Q4 2025, EBT Margin fell 2239.0% year-over-year to 5.76%; the TTM value through Dec 2025 reached 20.98%, down 748.0%, while the annual FY2025 figure was 20.98%, 748.0% down from the prior year.
  • EBT Margin reached 5.76% in Q4 2025 per EW's latest filing, down from 22.43% in the prior quarter.
  • Across five years, EBT Margin topped out at 49.17% in Q4 2022 and bottomed at 5.76% in Q4 2025.
  • Average EBT Margin over 5 years is 29.24%, with a median of 29.79% recorded in 2024.
  • Peak YoY movement for EBT Margin: surged 5783bps in 2021, then crashed -2961bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 28.3% in 2021, then skyrocketed by 74bps to 49.17% in 2022, then plummeted by -60bps to 19.56% in 2023, then skyrocketed by 44bps to 28.15% in 2024, then tumbled by -80bps to 5.76% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 5.76% in Q4 2025, 22.43% in Q3 2025, and 26.12% in Q2 2025.